{
  "ticker": "JNJ",
  "target_date": "2025-09-25",
  "actual_date": "2025-09-25",
  "collected_at": "2025-12-08T12:19:32.227544",
  "price": {
    "open": 176.08,
    "high": 177.27,
    "low": 174.8,
    "close": 176.60867309570312,
    "volume": 8475000,
    "change_1d_pct": 0.59,
    "change_7d_pct": 0.72,
    "change_30d_pct": 2.65
  },
  "technicals": {
    "rsi_14": 48.13,
    "sma_20": 175.88,
    "sma_50": 172.05,
    "macd": 0.911,
    "macd_signal": 1.343,
    "macd_histogram": -0.432,
    "bb_upper": 178.52,
    "bb_lower": 173.24,
    "price_vs_sma20_pct": 0.41,
    "price_vs_sma50_pct": 2.65,
    "volume_ratio": 1.02
  },
  "fundamentals": {
    "market_cap": 487424491520,
    "pe_ratio": 19.527992,
    "forward_pe": 19.085848,
    "price_to_book": 6.140468,
    "price_to_sales": 5.2895255,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.65,
    "pct_from_52w_low": 43.81
  },
  "macro": {
    "spy": {
      "price": 658.05,
      "change_1d_pct": -0.46,
      "change_7d_pct": 0.11
    },
    "vix": {
      "level": 16.74,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.17
    },
    "dollar_index": {
      "level": 98.55
    },
    "gold": {
      "price": 3736.9
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Will BDTX's EGFR Inhibitor Bring a Paradigm Shift in NSCLC Treatment?",
      "source": "Yahoo",
      "datetime": 1758819180,
      "summary": "Black Diamond's silevertinib aims to challenge Tagrisso, offering broad EGFR mutation coverage, as key trial results are expected in late 2025.",
      "url": "https://finnhub.io/api/news?id=a2ddea7070935b5a1f0b44665e291324b43e0d3d7fe2be433d826fafe26307d5"
    },
    {
      "headline": "AstraZeneca Stock Rises 15% YTD: Should You Buy, Sell or Hold?",
      "source": "Yahoo",
      "datetime": 1758815520,
      "summary": "AstraZeneca stock is up 15% so far in 2025 as blockbuster drugs and a robust oncology portfolio fuel growth despite looming headwinds.",
      "url": "https://finnhub.io/api/news?id=d31d6edd9854fc45e63b74d7037b162c23113955d0eef5fe36364406db0eaaf8"
    },
    {
      "headline": "Johnson & Johnson (JNJ) Could Be a Great Choice",
      "source": "Yahoo",
      "datetime": 1758815102,
      "summary": "Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",
      "url": "https://finnhub.io/api/news?id=7b2fdb341cac47f6a4cf2f881e2f64b68d101af8a6cd5831182d68bee5a37215"
    },
    {
      "headline": "Josh Brown Talks About Johnson & Johnson\u2019s (JNJ) Upcoming \u2018Big Catalyst\u2019",
      "source": "Yahoo",
      "datetime": 1758808526,
      "summary": "We recently published Wall Street Analysts Like These 10 Stocks. Johnson & Johnson (NYSE:JNJ) is one of the stocks analysts were recently talking about. Josh Brown, CEO of Ritholtz Wealth Management, explained in a latest program on CNBC why he likes Johnson & Johnson (NYSE:JNJ). Brown said the comp",
      "url": "https://finnhub.io/api/news?id=1e38a9db49f1d35097fd6e9c07ca80c4211594465014a44653b9bc68fde3fac4"
    },
    {
      "headline": "Hold These 5 \u2018Forever Assets\u2019 To Make Money in Your Sleep \u2014 Something Buffett Says Is a Must",
      "source": "Yahoo",
      "datetime": 1758806645,
      "summary": "Billionaire super-investor Warren Buffett has shared plenty of financial wisdom over his almost 70-year career. When addressing the subject of retirement planning, he famously said, \"If you don't find...",
      "url": "https://finnhub.io/api/news?id=51d297555c2b5c4db82662f2c3d01638077be8cab9677014ebeb23ff4be06cda"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627547.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000196/xslF345X05/wk-form4_1757627547.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627315.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000194/xslF345X05/wk-form4_1757627315.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627206.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000192/xslF345X05/wk-form4_1757627206.xml"
    },
    {
      "form": "8-K",
      "date": "2025-09-09",
      "description": "jnj-20250908.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000190/jnj-20250908.htm"
    },
    {
      "form": "4",
      "date": "2025-09-05",
      "description": "xslF345X05/wk-form4_1757109644.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000186/xslF345X05/wk-form4_1757109644.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}